Anbio Biotechnology (NASDAQ:NNNN) Sees Strong Trading Volume – What’s Next?

Anbio Biotechnology (NASDAQ:NNNN) saw an uptick in trading volume on Monday . 88,688 shares traded hands during trading, an increase of 17% from the previous session’s volume of 75,852 shares.The stock last traded at $5.4650 and had previously closed at $5.25.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings cut Anbio Biotechnology from a “hold (c-)” rating to a “sell (d+)” rating in a research note on Wednesday, July 29th. One research analyst has rated the stock with a Sell rating, According to MarketBeat, Anbio Biotechnology presently has a consensus rating of “Sell”.

Anbio Biotechnology Stock Performance

The firm has a 50 day moving average price of $8.27 and a two-hundred day moving average price of $17.78.

Anbio Biotechnology Company Profile

Anbio Biotechnology is dedicated to the advancement of medical technology and the provision of in vitro diagnostics (IVD) products. Our unwavering commitment lies in transforming the diagnostics landscape on a global scale, fostering a paradigm shift towards personalized and decentralized diagnostic solutions. By doing so, we aim to significantly enhance patient prognosis and contribute to the betterment of healthcare worldwide. At Anbio Biotechnology, our extensive portfolio comprises an array of IVD products designed to cater to diverse diagnostic needs.